A golden era for blood cancer treatments
It’s an exciting time in blood cancer research. As we deepen our understanding of the biology of blood cancer, researchers are developing better treatments than ever before, and we’re even beginning to talk about...
NETPark: the hi-tech force for growth in County Durham
NETPark of Durham provides world-class laboratory, clean room and office space to science, technology and engineering companies, ranging from start-ups to global AIM-listed firms.
Managed by Business Durham and backed by on-site strategic partner CPI...
Biosimilars set to make significant UK impact
Biosimilar medicines - equivalent biological products which have no meaningful differences from the original or reference product in terms of quality, safety or efficacy - are playing an important role in providing choice for...
Cancer cell ‘switch-off’ could aid deadly brain tumour treatment
Researchers believe they may have found a way to strengthen possible treatments for glioblastoma and reduce the speed at which the aggressive tumour progresses.
Glioblastoma is the most common primary brain tumour in adults, and,...
Genome sequencing reveals how salmonella carves out a niche in pork production
Variants of concern (VOCs) and variants of interest (VOIs) have become familiar terms due to the current pandemic, but variants of familiar pathogens such as salmonella also present a threat to human and animal...
Tackling the trillion dollar Alzheimer’s disease
It’s almost impossible to conceive the complexity that lies ahead in the challenge to address Alzheimer’s disease. But, picture standing in front of an old mansion house, completely overgrown with ivy, trees, and shrubs....
Maternal microbiome promotes baby’s healthy development
Researchers studying mice have found the first evidence of how a mother’s gut microbes, the maternal microbiome, can help in the development of the placenta, and the healthy growth of the baby.
Scientists from the...
‘Avatar’ motion tech aids advances in disease research
AI and motion capture technology are helping track the progression of rare genetic diseases affecting movement - and could ultimately be used to monitor common medical conditions like strokes.
In two ground-breaking studies, published in...
What makes a spinout?
Universities carry out research into some of the most fundamental questions about life and the world around us, with researchers utilising specialist facilities and equipment to investigate and advance human knowledge.
This doesn’t happen overnight,...
Euro biotech: breaking down the barriers to a golden age
Converting cutting-edge research into viable products remains a challenge for the European biotech sector. Jonathan Hay of Delin Ventures investigates how ambition can translate to reality.
Europe’s tech sector is going from strength to strength....
Games and stimulation mitigate cognitive decline in older adults
Older people may be able to boost their working memory with a new approach that couples online therapeutic games with a non-invasive brain stimulation technique.
Working memory is critical for people to function well in...
Unravelling the DNA dilemma: A new chapter in rare disease research
‘Hope is not lost’ for the 50 per cent of people with undiagnosed rare diseases, says UK genomics expert Neil Ward, of PacBio. New technologies can provide more accurate, in-depth data on the genome,...
AI-powered simulations pair drugs with cancer patients
Finding solutions to complex diseases is top of the agenda for a collaboration between a leading UK innovation engine and a Budapest-based biotech firm.
Cancer Research Horizons is part of Cancer Research UK, the world’s...
CRYONISS EARNS COVETED MHRA QUALITY MARK
Experts in biological sample, and medicinal product, storage and logistics management, CRYONISS offers a comprehensive storage service from ambient down to vapour phase liquid nitrogen.
The Cheshire-based team has a wealth of experience in supporting...
Synthetic mouse embryo models created from stem cells
An egg meets a sperm -- the necessary first step for life and a common first step in embryonic development research. But now researchers have grown synthetic embryo models of mice outside the womb...
90 years on, the time-bomb of antibiotic resistance
By Professor Colin Garner
The events of 28 September 1928 could justifiably lay claim to being called the most significant breakthrough in medical history.
With typical ingenuity and a quantity of genius, Sir Alexander Fleming discovered...